Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jindan Yu

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Research Square|June 19, 2023
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic targetMarina Ferrari, Li Wang, Luke Hoeppner, et al.
Pediatrics|May 4, 2026
Simultaneous TFAM and TJP2 Variants in a Child With Cirrhosis and Hepatocellular CarcinomaJindan Yu, Hong Zhao, Youyou Lou, et al.
Cancer Research|August 6, 2013
ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancerLongtao Wu, Jonathan C Zhao, Jung Kim, et al.
Serican Journal of Medicine|February 9, 2026
Appropriate normalization is critical to improve reproducibility of tissue ChIP-seqQi Chu, Liu Peng, Lourdes Brea, et al.
Molecular Vision|May 16, 2002
Evaluation and optimization of procedures for target labeling and hybridization of cDNA microarraysJindan Yu, Mohammad I Othman, Rafal Farjo, et al.
Oncogene|August 5, 2021
Going beyond Polycomb: EZH2 functions in prostate cancerSu H Park, Ka-Wing Fong, Ezinne Mong, et al.
Virology Journal|May 29, 2026
Divergent immunometabolic landscapes of chicken and swan goose identify SERPINF2 as a novel restriction factor for influenza A virusFangbing Li, Chenyang Ren, Wanlin Liu, et al.
Clinical Genetics|April 5, 2024
Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IXJindan Yu, Xiuxin Ling, Lingli Chen, et al.
Molecular Cell|December 8, 2022
PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencingKa-Wing Fong, Jonathan C Zhao, Xiaodong Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2025
Extracellular vesicle-mediated delivery of CRISPR machinery silences androgen receptor in castration-resistant prostate cancer cellsChenming Ye, Yongjie Ma, Raunak Shrestha, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Research Square|June 19, 2023
Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic targetMarina Ferrari, Li Wang, Luke Hoeppner, et al.
Pediatrics|May 4, 2026
Simultaneous TFAM and TJP2 Variants in a Child With Cirrhosis and Hepatocellular CarcinomaJindan Yu, Hong Zhao, Youyou Lou, et al.
Cancer Research|August 6, 2013
ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancerLongtao Wu, Jonathan C Zhao, Jung Kim, et al.
Serican Journal of Medicine|February 9, 2026
Appropriate normalization is critical to improve reproducibility of tissue ChIP-seqQi Chu, Liu Peng, Lourdes Brea, et al.
Molecular Vision|May 16, 2002
Evaluation and optimization of procedures for target labeling and hybridization of cDNA microarraysJindan Yu, Mohammad I Othman, Rafal Farjo, et al.
Oncogene|August 5, 2021
Going beyond Polycomb: EZH2 functions in prostate cancerSu H Park, Ka-Wing Fong, Ezinne Mong, et al.
Virology Journal|May 29, 2026
Divergent immunometabolic landscapes of chicken and swan goose identify SERPINF2 as a novel restriction factor for influenza A virusFangbing Li, Chenyang Ren, Wanlin Liu, et al.
Clinical Genetics|April 5, 2024
Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IXJindan Yu, Xiuxin Ling, Lingli Chen, et al.
Molecular Cell|December 8, 2022
PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencingKa-Wing Fong, Jonathan C Zhao, Xiaodong Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2025
Extracellular vesicle-mediated delivery of CRISPR machinery silences androgen receptor in castration-resistant prostate cancer cellsChenming Ye, Yongjie Ma, Raunak Shrestha, et al.
Pageof 13